fbpx
Colour
C C C C C
Text
T T
Skip To Content
Feb 8, 2019

Shorcan Charity Day Raises Another $10,000 for Vision Research

Cycle for Sight Event

On January 24, 2018, Shorcan Brokers Limited contributed $10,000 to Fighting Blindness Canada (FBC) as part of its 21st Annual Charity Day.

Every year, Shorcan, TMX Group’s fixed income interdealer brokerage, donates one day’s profit to a variety of designated charities. 2019 marks the 11th year that Fighting Blindness Canada has been a beneficiary of Shorcan’s Annual Charity Day, and brings Shorcan’s total contributions to FBC to $92,661!

Shorcan’s generous support will support sight-saving research into blinding eye diseases and will give hope to the over one million Canadians living with vision loss.

“I’d like to express our sincerest gratitude to Shorcan for their generous support,” said Ann Morrison, Director of Philanthropy at Fighting Blindness Canada. “Thanks to their yearly contribution, vision research continues to advance towards the ultimate goal of making treatments and cures accessible to all Canadians.”

Photo Caption: (L-R) Michael Gibbens, President of Shorcan; Doug Earle, President and CEO of FBC; Dave Sweeny, Past FBC Board Member; Ann Morrison, Director of Philanthropy, FBC; Frank Salmonds, Managing Director of RBC Capital Markets.

Latest FBC News View All

Collage of photos
Apr 25, 2019

A Message from the President and CEO For 45 years, the Foundation Fighting Blindness has raised and directed critical funding into sight-saving research for blinding eye diseases. From our earliest days as…

Read More
Sep 9, 2019

This year, participants in Cycle for Sight events across the country set off on exciting routes through farmland, fields, and country lanes. As with any adventure, our cyclists occasionally came across the…

Read More
Sep 5, 2019

Alongside our partners at the Canadian Retina Society, the Canadian Council of the Blind, and Novartis, we’re raising awareness about the signs and symptoms of age-related macular degeneration. Check out our PSA,…

Read More
Laboratory Researchers
Sep 5, 2019

This month, the Inherited Retinal Dystrophies Consortium Operating for the Under-Represented for Novel Therapies and Services (IRD COUNTS) released a landmark study highlighting the personal costs of living with an inherited retinal…

Read More

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our eNews.

I have read and accepted the privacy policy